TR200400189T2 - Esitalopram içeren kristal yapılı bileşim. - Google Patents

Esitalopram içeren kristal yapılı bileşim.

Info

Publication number
TR200400189T2
TR200400189T2 TR2004/00189T TR200400189T TR200400189T2 TR 200400189 T2 TR200400189 T2 TR 200400189T2 TR 2004/00189 T TR2004/00189 T TR 2004/00189T TR 200400189 T TR200400189 T TR 200400189T TR 200400189 T2 TR200400189 T2 TR 200400189T2
Authority
TR
Turkey
Prior art keywords
composition containing
crystalline composition
containing escitalopram
escitalopram
particles
Prior art date
Application number
TR2004/00189T
Other languages
English (en)
Inventor
Volsgaard Christensen Troels
Liljegren Ken
Onne Elema Michiel
Andresen Lene
Mahashabde Shashank
Assenza P.Sebastian
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200400189(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of TR200400189T2 publication Critical patent/TR200400189T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

En az 40 mikrometrelik bir parçacik boyutuna sahip, kristal yapili esitalopram oksalat parçaciklari anlatilmistir. Diger yandan, adi geçen kristal yapili parçaciklarin imal edilmesine yönelik yöntem ve adi geçen kristal yapili parçaciklari içeren ilaç bilesimleri de anlatilmistir.
TR2004/00189T 2001-07-31 2002-07-25 Esitalopram içeren kristal yapılı bileşim. TR200400189T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101164 2001-07-31

Publications (1)

Publication Number Publication Date
TR200400189T2 true TR200400189T2 (tr) 2004-12-21

Family

ID=8160647

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/00189T TR200400189T2 (tr) 2001-07-31 2002-07-25 Esitalopram içeren kristal yapılı bileşim.

Country Status (39)

Country Link
US (3) US6916941B2 (tr)
EP (2) EP1414435B1 (tr)
JP (4) JP2005525993A (tr)
KR (1) KR20040028947A (tr)
CN (2) CN1311819C (tr)
AR (1) AR034898A1 (tr)
AT (2) ATE352546T1 (tr)
AU (1) AU2002355624B2 (tr)
BG (1) BG108571A (tr)
BR (1) BR0206164A (tr)
CA (1) CA2451915C (tr)
CO (1) CO5560540A2 (tr)
CY (1) CY1106413T1 (tr)
DE (2) DE60217932T2 (tr)
DK (2) DK1414435T3 (tr)
EA (1) EA006213B1 (tr)
EG (1) EG24206A (tr)
ES (2) ES2280892T3 (tr)
HR (2) HRP20031073A2 (tr)
HU (1) HUP0401946A2 (tr)
IL (2) IL159326A0 (tr)
IS (1) IS7077A (tr)
MA (1) MA27349A1 (tr)
ME (1) MEP2108A (tr)
MX (1) MXPA04000849A (tr)
MY (1) MY126238A (tr)
NO (1) NO328346B1 (tr)
NZ (1) NZ530157A (tr)
PE (1) PE20030304A1 (tr)
PL (1) PL366995A1 (tr)
PT (2) PT1414435E (tr)
RS (1) RS8304A (tr)
SI (1) SI1414435T1 (tr)
TN (1) TNSN04021A1 (tr)
TR (1) TR200400189T2 (tr)
UA (1) UA79930C2 (tr)
UY (1) UY27404A1 (tr)
WO (1) WO2003011278A1 (tr)
ZA (1) ZA200309684B (tr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145615A0 (en) 1999-04-14 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
ATE352546T1 (de) * 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) * 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
NZ549100A (en) * 2004-03-05 2010-02-26 Lundbeck & Co As H Crystalline composition containing escitalopram oxalate
US20110196032A1 (en) * 2005-05-20 2011-08-11 Ashish Gogia Pharmaceutical Dosage Form of an Antidepressant
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR20070067173A (ko) * 2005-08-29 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이정점 입도 분포를 갖는 고체 미립자 타달라필
KR20080080094A (ko) 2005-10-14 2008-09-02 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
US8252336B2 (en) 2006-10-20 2012-08-28 Ratiopharm Gmbh Escitalopram and solid pharmaceutical composition comprising the same
US20090048336A1 (en) * 2007-08-17 2009-02-19 Naveen Kumar Kolla Escitalopram oxalate powders
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2116231A1 (en) 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
GR20080100696A (el) 2008-10-23 2010-05-13 Genepharm �.�. Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120448A1 (it) * 2012-01-30 2013-07-31 Carthesia Sas Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
ITMI20120106A1 (it) * 2012-01-30 2013-07-31 Carthesia S A S Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
WO2017020841A1 (zh) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
WO2018190294A1 (ja) * 2017-04-10 2018-10-18 東和薬品株式会社 エスシタロプラム医薬組成物
CN107441052A (zh) * 2017-06-21 2017-12-08 山东京卫制药有限公司 一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) * 2017-11-01 2020-03-16 한국화학연구원 에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja) * 2020-06-22 2024-03-21 東和薬品株式会社 エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (tr) 1965-03-18
GB1358915A (en) 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
EP0223403B1 (en) 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
GB9325644D0 (en) 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5683720A (en) 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AU5966196A (en) 1995-06-08 1997-01-09 Eli Lilly And Company Methods of treating cold and allergic rhinitis
JP3526581B2 (ja) 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
GB9714841D0 (en) 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
US5980941A (en) 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US5869098A (en) 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5840334A (en) 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CN1286687A (zh) * 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
WO2000023431A1 (en) 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
IL145615A0 (en) 1999-04-14 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
WO2001022941A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
ATE352546T1 (de) * 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram

Also Published As

Publication number Publication date
NZ530157A (en) 2007-06-29
SI1414435T1 (en) 2005-06-30
MY126238A (en) 2006-09-29
EA006213B1 (ru) 2005-10-27
US7420069B2 (en) 2008-09-02
DE60217932T2 (de) 2007-08-30
JP2012211186A (ja) 2012-11-01
CO5560540A2 (es) 2005-09-30
HRPK20080410B3 (en) 2009-09-30
CY1106413T1 (el) 2011-10-12
CA2451915C (en) 2010-09-21
DK1522539T3 (da) 2007-05-07
BR0206164A (pt) 2003-10-28
EP1522539B1 (en) 2007-01-24
PT1522539E (pt) 2007-03-30
JP5719811B2 (ja) 2015-05-20
ES2280892T3 (es) 2007-09-16
ATE352546T1 (de) 2007-02-15
MEP2108A (xx) 2010-02-10
HUP0401946A2 (hu) 2005-01-28
PL366995A1 (en) 2005-02-07
EP1414435A1 (en) 2004-05-06
EP1522539A1 (en) 2005-04-13
ZA200309684B (en) 2004-12-22
CN1660074A (zh) 2005-08-31
IS7077A (is) 2003-12-15
ATE286730T1 (de) 2005-01-15
NO328346B1 (no) 2010-02-01
MA27349A1 (fr) 2005-06-01
BG108571A (en) 2005-02-28
DK1414435T3 (da) 2005-05-09
US20030212128A1 (en) 2003-11-13
UY27404A1 (es) 2003-02-28
EA200400243A1 (ru) 2004-06-24
CN1311819C (zh) 2007-04-25
DE60202615D1 (de) 2005-02-17
HRP20080410A2 (en) 2008-10-31
HK1070000A1 (en) 2005-06-10
US20080305164A1 (en) 2008-12-11
EP1414435B1 (en) 2005-01-12
JP2005525993A (ja) 2005-09-02
IL159326A0 (en) 2004-06-01
JP5192568B2 (ja) 2013-05-08
CA2451915A1 (en) 2003-02-13
NO20040380L (no) 2004-01-28
ES2233842T3 (es) 2005-06-16
MXPA04000849A (es) 2004-05-14
PT1414435E (pt) 2005-05-31
JP2011195591A (ja) 2011-10-06
TNSN04021A1 (en) 2006-06-01
US6916941B2 (en) 2005-07-12
JP4971477B2 (ja) 2012-07-11
CN1536997A (zh) 2004-10-13
HRP20031073A2 (en) 2004-04-30
AR034898A1 (es) 2004-03-24
AU2002355624B2 (en) 2006-02-02
WO2003011278A1 (en) 2003-02-13
EG24206A (en) 2008-10-21
KR20040028947A (ko) 2004-04-03
DE60202615T2 (de) 2006-01-12
JP2010150283A (ja) 2010-07-08
US20050147674A1 (en) 2005-07-07
UA79930C2 (en) 2007-08-10
DE60217932D1 (de) 2007-03-15
PE20030304A1 (es) 2003-03-27
RS8304A (sr) 2006-12-15
IL159326A (en) 2010-05-31

Similar Documents

Publication Publication Date Title
BG108571A (en) Crystalline composition containing escitalopram
HUP9903536A2 (hu) Bázikus anyaggal stabilizált gyógyászati készítmények
NO973922D0 (no) Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
BR9916835A (pt) Composição de galantamina de liberação controlada
BR9912472A (pt) Processos para fabricação de peneiras moleculares
FI970825A7 (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyö tyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
CA2387201A1 (en) Tetrahydroquinoline derivatives
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
CA2278201A1 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
BR9810495A (pt) Composição farmacêutica
CA2288677A1 (en) Novel powder compositions
BR0209489A (pt) Composições farmacêuticas
EP1218001A4 (en) ULTRAFINE L-CARNITINE, METHOD FOR THE PRODUCTION THEREOF, COMPOSITIONS CONTAINING THEREOF AND METHOD FOR THEIR USE
DE69941255D1 (de) Verbindungen mit wachstumshormon freisetzenden eigenschaften
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
DK1147068T3 (da) Fast sammensætning, der indeholder faste partikler og bindemiddel
CA2340224A1 (en) Nimesulide containing topical pharmaceutical compositions
IS5958A (is) 3, 4, 5-þrístaðgengin arýlnítronefnasambönd og lyfjablöndur sem slík efnasambönd eru í
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
JPH10219144A5 (tr)
CA2219311A1 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives, method for their production and pharmaceutical compositions containing them
CY2007011I1 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
DE69111607D1 (de) Reine kristalline form von rifapentin.
IT1269508B (it) Procedimento per la preparazione di particelle lavorate a secco, particelle lavorate a secco cosi' ottenute e composizioni farmaceutiche contenenti le particelle